Inhibiting EGFR Signaling Holds Promise for Treating Palmoplantar Keratodermas

J Invest Dermatol. 2023 Feb;143(2):185-188. doi: 10.1016/j.jid.2022.09.653.
No abstract available

Publication types

  • Comment

MeSH terms

  • ErbB Receptors / genetics
  • Humans
  • Keratins
  • Keratoderma, Palmoplantar* / drug therapy
  • Keratoderma, Palmoplantar* / genetics

Substances

  • Keratins
  • ErbB Receptors
  • EGFR protein, human